Viewing Study NCT02492568


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2026-02-11 @ 6:57 AM
Study NCT ID: NCT02492568
Status: COMPLETED
Last Update Posted: 2020-08-17
First Post: 2015-06-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC
Sponsor: The Netherlands Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module